TLX

4.06%

$14.88

TELIX PHARMACEUTICALS LIMITED

Market Cap $4.917B Add to my watchlist

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The Company is developing a portfolio of clinical-stage products that focuses to address the unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). The Company’s lead programs include TLX591-CDx (Illuccix) / TLX591 for diagnosis and treatment of metastatic castrate-resistant prostate cancer, TLX250-CDx/TLX250 for diagnosis and treatment of renal (kidney) cancer, TLX101-CDx / TLX101 for diagnosis and treatment of glioblastoma (brain cancer), and TLX66-CDx (Scintimun) / TLX66 for the treatment of bone marrow conditioning and rare diseases. The Company also owns SENSEI radio-guided surgery business.More

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutioniSe neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University,...

Latest Threads

Tag

Subject

TLX Biotech

Understanding Telix

10 11 12

10:03

683

308K

10:03

Last post mnbvcxz12345

683

308K

TLX

Ann: Telix Q1 2024 Revenue and Business Update

02:38

110

34K

02:38

Last post 76790759

110

34K

TLX

Short Term trading, analysis and TLX noise - No investors keep out

5 6 7

24/04/24

380

111K

24/04/24

Last post mnbvcxz12345

380

111K

TLX

TLX Chart

25 26 27

24/04/24

1.5K

557K

24/04/24

Last post Matt777

1.5K

557K

TLX

Ann: Pending Release of Shares from Voluntary Escrow

23/04/24

1.5K

23/04/24

Last post mnbvcxz12345

1.5K

TLX

Ann: Telix Notice of AGM, Proxy Form and Online Guide

22/04/24

3.1K

22/04/24

Last post Neckdeep

3.1K

TLX

Ann: Pending Release of Shares from Voluntary Escrow

18/04/24

361

18/04/24

Last post

ASX News

361

TLX

News: TLX Telix Pharmaceuticals Posts Q1 Unaudited Total Revenue Of $114 Mln

17/04/24

223

17/04/24

Last post

Hot News

223

See All Discussions

Timeline

Pending Release of Shares from Voluntary Escrow
23 Apr 13:51	Share

Telix Notice of AGM, Proxy Form and Online Guide
22 Apr 08:40	Share

Pending Release of Shares from Voluntary Escrow
18 Apr 08:26	Share

Telix Q1 2024 Revenue and Business Update
17 Apr 16:07	Share

TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
16 Apr 08:24	Share

Cleansing Notice
11 Apr 14:02	Share

Application for quotation of securities - TLX
11 Apr 14:02	Share

Telix Completes Acquisition of ARTMS
11 Apr 14:02	Share

Notification of cessation of securities - TLX
10 Apr 08:25	Share

Cleansing Notice
09 Apr 08:24	Share

Application for quotation of securities - TLX
09 Apr 08:24	Share

Cleansing Notice
09 Apr 08:23	Share

Application for quotation of securities - TLX
09 Apr 08:23	Share

Telix Completes Acquisition of IsoTherapeutics
09 Apr 08:23	Share

Telix General Meeting Results
05 Apr 12:06	Share

Telix General Meeting Presentation
05 Apr 10:02	Share

Telix General Meeting Chairman and CEO Addresses
05 Apr 10:02	Share

Notification regarding unquoted securities - TLX
27 Mar 08:26	Share

Cleansing Notice
21 Mar 08:24	Share

Application for quotation of securities - TLX
21 Mar 08:24	Share

Appointment of Darren Patti to Group Chief Operating Officer
12 Mar 08:25	Share

Telix Notice of General Meeting, Proxy Form and Online Guide
06 Mar 08:19	Share

Proposed issue of securities - TLX
05 Mar 09:17	Share

Presentation to Accompany ARTMS Acquisition
05 Mar 09:16	Share

Telix to Acquire ARTMS (Isotope Production Platform)
05 Mar 09:16	Share

Proposed issue of securities - TLX
27 Feb 08:01	Share

Telix to Acquire IsoTherapeutics (US R&D and Manufacturing)
27 Feb 08:01	Share

Appendix 4G and 2023 Corporate Governance Statement
22 Feb 18:36	Share

2023 Full Year Results Presentation
22 Feb 18:35	Share

2023 Full Year Results Release
22 Feb 18:35	Share

View More

(20min delay)
Last $14.88		Change 0.580(4.06%)		Mkt cap ! $4.917B

Open	High	Low	Value	Volume
$14.52	$14.99	$14.44	$25.56M	1.735M

Buyers (Bids)

No.	Vol.	Price($)
1	1800	$14.87

Sellers (Offers)

Price($)	Vol.	No.
$14.94	2000	1

View Market Depth

No.	Vol.	Price($)
1	1800	14.870
1	488	14.810
1	130	14.800
2	1902	14.750
1	2500	14.720

Price($)	Vol.	No.
14.940	2000	1
14.950	2080	2
14.990	247	2
15.000	38329	14
15.010	750	1

Last trade - 16.10pm 25/04/2024 (20 minute delay)


Last $14.86		Change 0.580 ( 4.06 %)
Open	High	Low	Volume
$14.52	$14.99	$14.43	355745
Last updated 15.59pm 25/04/2024 ?

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection

Telix Pharmaceuticals has been granted Fast Track designation by the FDA for its brain cancer imaging software; TLX101-CDx

Telix Pharmaceuticals finalises acquisition of IsoTherapeutics

Telix Pharmaceuticals (ASX:TLX) has acquired one of its service suppliers - IsoTherapeutics Group - in a deal worth more than A$20 million.

Telix Boosts U.S. Presence with IsoTherapeutics Acquisition

Melbourne-based Telix Pharmaceuticals (ASX: TLX) has sealed the deal to acquire IsoTherapeutics Group, LLC

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News